Pancreatic Cancer Research

ResearcherUniversitätsmedizin GöttingenActive in the last 2 years

Marian Grade

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9527-5362; OpenAlex author ID A5041792287. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2022: 2 papers · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 6

  1. The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/mco2.70794↗
  2. Targeting PRMT5 Inhibitor-Induced Adaptation in Pancreatic Cancer with the RBM39 Degrader Indisulam. Co-author DOI 10.1158/2767-9764.crc-25-0670↗
  3. KRAS G 12C-inhibitor-based combination therapies for pancreatic cancer: insights from drug screening. Co-author DOI 10.1002/1878-0261.13725↗
  4. A Novel AMPK Inhibitor Sensitizes Pancreatic Cancer Cells to Ferroptosis Induction. Co-author DOI 10.1002/advs.202307695↗
  5. AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancer. Co-author DOI 10.1007/s00018-022-04638-y↗
  6. Targeting STAT3 Signaling Facilitates Responsiveness of Pancreatic Cancer Cells to Chemoradiotherapy. Last author DOI 10.3390/cancers14051301↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Günter Schneider · 6 shared papers, 2022–2026 · strength 0.99
  2. Maximilian Reichert · 5 shared papers, 2022–2026 · strength 0.83
  3. Lukas Krauß · 5 shared papers, 2022–2026 · strength 0.83
  4. Carolin Schneider · 5 shared papers, 2022–2026 · strength 0.83
  5. Elisabeth Heßmann · 5 shared papers, 2022–2026 · strength 0.83
  6. Matthias Wirth · 5 shared papers, 2022–2026 · strength 0.83
  7. Dieter Saur · 5 shared papers, 2022–2026 · strength 0.83
  8. Michael B. Ghadimi · 4 shared papers, 2024–2026 · strength 0.71
  9. Volker Ellenrieder · 4 shared papers, 2024–2026 · strength 0.71
  10. Christian Schneeweis · 4 shared papers, 2022–2026 · strength 0.62
  11. Constanza Tapia Contreras · 3 shared papers, 2024–2026 · strength 0.50
  12. Roland Rad · 3 shared papers, 2022–2026 · strength 0.45
  13. Lena‐Christin Conradi · 2 shared papers, 2025–2026 · strength 0.38
  14. Felix Orben · 2 shared papers, 2024–2026 · strength 0.33
  15. Jochen Gaedcke · 2 shared papers, 2022–2025 · strength 0.33
  16. Oliver Holger Krämer · 2 shared papers, 2022–2026 · strength 0.31
  17. Chiara Falcomatà · 2 shared papers, 2022–2024 · strength 0.26
  18. Valentina Spielmann · 1 shared paper, 2026 · strength 0.21
  19. Ulrich Bernd Keller · 1 shared paper, 2026 · strength 0.19
  20. Hazal Köse · 1 shared paper, 2026 · strength 0.19
  21. Roland Michael Schmid · 1 shared paper, 2026 · strength 0.19
  22. Janine Murr · 1 shared paper, 2026 · strength 0.19
  23. Alexandra Nguyen · 1 shared paper, 2026 · strength 0.19
  24. Sebastian Mueller · 1 shared paper, 2026 · strength 0.19
  25. Gabriela Salinas · 1 shared paper, 2025 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.